Amuvatinib hydrochloride is a multi-targeted tyrosine kinase inhibitor with potent activity against mutant c-Kit, PDGFRα, Flt3, c-Met, and c-Ret; it also acts as a DNA repair inhibitor by targeting the DNA repair protein RAD51, thereby disrupting DNA damage repair, and exhibits antitumor activity.